NEW YORK (AP) - Increasing excitement from surgeons about new bone graft substitute products will propel that market to $1.9 billion in 2012, according to a new report. According to Millennium Research Group's US Markets for Orthopedic Biomaterials 2008 report, the introduction of advanced BGS...
